Clinical practice guide: Team approach to Hypertrophic cardiomyopathy cat (HCM)

Author: Veterinarian Susanne Arndt, Medical Director / Owner
Studies: Faculty of Veterinary Medicine, University of Leipzig
Career path: 6 years as assistant veterinarian at the small animal clinic of Dr. Thomas Graf (Cologne); 1 year setting up the small animal department at the Lahr Animal Health Center; since 2013 owner of small animal practices in Karlsbad-Ittersbach & Karlsbad-Langensteinbach
Further education: Master's degree in Small Animal Science (FU Berlin), ongoing training in osteosynthesis
Memberships: German Veterinary Medical Society, Working Group on Feline Medicine (DGK-DVG), Working Group on Laser Medicine (DGK-DVG)

---

What is hypertrophic Cardiomyopathy with the cat?

As a practising vet, I see Hypertrophic cardiomyopathy cat Very common – it is the most widespread heart disease in cats. This refers to a concentric thickening of the left ventricular wall without any other disease that could explain this characteristic. Unlike secondary cardiac changes (e.g., hyperthyroidism or acromegaly), in this case Hypertrophic cardiomyopathy cat Structurally altered heart muscle cells are present, arranged in a disordered manner (myocardial "disarray") and not functioning normally. This leads to a stiffer heart chamber, reduced filling during diastole, and often to enlargement of the left atrium.

In my practice, I regularly see that affected cats initially show no noticeable symptoms. This subclinical phase is insidious: Although Hypertrophic cardiomyopathy cat Although the disease has already caused measurable changes in the heart, the animals often appear normal at home. The first clinical signs frequently appear in adulthood; in some cases, we see them considerably earlier. Internationally, prevalences of approximately 10–15 µg/µg of µg/µg are reported in the general population, and significantly higher in some breeds. Ragdolls, Maine Coons, British Shorthairs, American Shorthairs, Bengals, Persians, Siberians, and Sphynx cats have an increased risk – a link to genetic factors is considered established. For a more in-depth overview, I recommend the ACVIM consensus guidelines and the overview from the Cornell Feline Health Center, which clearly summarize the pathophysiology and breed predisposition. Wiley Online Library+1

Pathophysiologically, the thickening of the heart wall leads to reduced blood flow to the myocardium. This can trigger microscopic necrosis and fibrotic remodeling. Elasticity decreases, the left ventricle fills less efficiently, the left atrium enlarges, and dynamic obstruction of the left ventricular outflow tract (SAM of the mitral valve leaflets) can develop. In advanced stages, this results in increased pressures in the pulmonary circulation, pulmonary edema, pleural effusion, and consequently, left ventricular failure. The risk of arterial thromboembolism also increases – the "saddle thrombus" at the aortic bifurcation is particularly feared. These relationships are described in detail in review articles and guidelines. Wiley Online Library+1

How does it make itself Hypertrophic cardiomyopathy cat Noticeable?

Many cats remain asymptomatic for a long time. A heart murmur may be present, but it is neither specific nor sensitive. Arrhythmias (supraventricular or ventricular extrasystoles, ventricular tachycardia) also occur. When clinical consequences do appear, we most frequently see: increased respiratory rate, dyspnea, reduced exercise tolerance; in cases of thromboembolism, sudden painful hind limb paralysis with cold, pale paw pads; in rare cases, sudden cardiac death. It is important for owners to know that coughing in cats – unlike in dogs – no A typical sign of heart failure. Cornell University offers detailed, lay-friendly information. Cornell Vet Med

Diagnostic process in practice

In general practice, the evaluation begins with a thorough clinical examination, including auscultation. I also like to use NT-proBNP – either as a laboratory test or as a point-of-care rapid test – to assess cardiac stress. This biomarker rises with cardiac stress; it is helpful, but not a substitute for ultrasound. In stable cats with abnormal findings, I recommend referral for echocardiography (the gold standard). X-rays can be useful in cases of dyspnea/effusion, but are not recommended. not as a screening for mild Hypertrophic cardiomyopathy cat. Regarding the role of NT-proBNP, including its strengths and limitations, good overviews and data can be found in JAVMA and training materials; in emergencies, the SNAP test can also help differentiate cardiac dyspnea. AVMA Journals+2IDEXX+2

Echocardiography provides crucial information: wall thicknesses (e.g., IVSd, LVPWd), papillary muscle hypertrophy, SAM, extent of atrial enlargement, flow profiles, and—if necessary—pressure gradients in the outflow tract. The ACVIM staging system allows for differentiation of the risk of life-threatening events (CHF, aortic thromboembolism, sudden death) and the structuring of follow-up care. Wiley Online Library+1

Therapy – subclinical stage vs. clinical disease

With Hypertrophic cardiomyopathy cat In the subclinical stage, traditionally, the focus has been primarily on risk reduction measures: thromboembolism prophylaxis in cases of moderate to severe atrial enlargement (e.g., clopidogrel) and rhythm control in individual cases of ventricular arrhythmias (e.g., atenolol). Fluid therapy is administered very cautiously. In cases of acute clinical decompensation (CHF, ATE), treatment is strictly dependent on the situation (oxygen, diuretics, thoracentesis, analgesia, and, if necessary, anticoagulation). These principles are reflected in international consensus and current review articles. Wiley Online Library+1

What's new is that there has been a [new regulation/implementation] in the USA since March 2025. conditionally permitted There is therapy that targets the underlying cause of the disease: Felycin®-CA1 (sirolimus, delayed-release tablets) for Treatment of ventricular hypertrophy in cats with subclinical Hypertrophic cardiomyopathy cat. The FDA granted conditional approval (NADA 141-604); market launch took place in summer 2025. In a six-month study of 43 cats, Felycin-CA1 significantly reduced wall thickness compared to placebo, without an increase in adverse events.

The recommended dose is 0.3 mg/kg orally once weekly. Contraindications include diabetes mellitus, liver disease, existing ATE, and overt heart failure; caution is advised in cases of concomitant CYP3A4/P-gp inhibitors and MDR1 mutation. For details regarding indication, safety, and regulatory status, please refer to FDA documentation and manufacturer's information. Innovation News Network+3Animal approval FDA+3DVM360+3

My daily practice routine: I discuss risk-based screenings with owners (e.g., breed, murmur, NT-proBNP, echocardiography), explain the importance of regular respiratory rate checks at home (resting respiration ≤ 30/min), and agree on clear recheck intervals. For cats with large atria and no contraindications, I discuss anticoagulation. For suitable subclinical patients, I address – depending on the location – access to felycin-CA1, off-label use abroad, and the need for close follow-up.

---

The effects of Hypertrophic cardiomyopathy cat

Hypertrophic cardiomyopathy cat The course of the disease is heterogeneous: some cats die shortly after diagnosis, while others reach a normal lifespan without clinical events. The prognosis depends on factors such as wall thickness, atrial size, the presence of SAM/obstruction, arrhythmias, biomarkers, and the development of CHF or thromboembolism. Large left atria, repeated decompensated episodes, and early-onset thromboembolism are associated with a poor prognosis. International reviews categorize these factors into useful risk stratifications, which we use in practice for patient counseling. MDPI

For Halter, the key is that early detection and a structured team approach improve the likelihood of delaying complications and maintaining a high quality of life. The spectrum of care ranges from consistent documentation of respiratory rate and medication administration to weight management (excess weight increases respiratory load) and clear emergency plans.

---

Diagnostics of Hypertrophic cardiomyopathy cat

Screening & Initial Assessment:

• Auscultation (Noises, arrhythmias) – not conclusive, but an indication.
• NT-proBNP As a pragmatic tool in practice: It aids in triage, in differentiating cardiac dyspnea, and in deciding whether a referral for ultrasound is a priority. Interpretation is always in the context of blood pressure and thyroid function. AVMA Journals+1
• Chest X-rayUseful in cases of dyspnea for assessing congestion/effusion, but not suitable as a screening test for mild cases Hypertrophic cardiomyopathy cat not very sensitive.
• Echocardiography: Gold standard for diagnosis, phenotyping and prognostic assessment, according to ACVIM consensus. Wiley Online Library

Rechecks: The interval depends on the stage (e.g., 6–12 months for subclinically low risk, shorter for high-risk situations). In practice, a fixed schedule with defined communication to the owners has proven effective.

---

Management of subclinical Hypertrophic cardiomyopathy cat

The goals are: delaying progression, preventing CHF episodes, thromboembolism, and sudden cardiac death.

• Anticoagulation: Clopidogrel is the standard treatment in cases of significantly enlarged left atrium (and other risk factors).
• Arrhythmias: Selective beta-blockers (e.g., atenolol) for ventricular ectopia.
• New option: Felycin®-CA1 for targeted reduction of hypertrophy in suitable subclinical patients (observe indication limits, contraindications and interactions; regular check-ups). Animal approval FDA+1
• Fluid therapy: Be cautious, as over-infusion can occur. Hypertrophic cardiomyopathy cat It can trigger decompensation.
• Owner Education: Measure breathing rate during sleep, minimize stress, know emergency signs (shortness of breath, sudden paralysis, severe apathy).

---

Team roles in the care of cats with HCM

A structured team approach improves the quality of care:

Registration/Telephone: Communicate the value of preventative check-ups; arrange for immediate appointments in case of warning signs (e.g., shortness of breath, acute lameness); reliably schedule follow-up appointments; provide empathetic support.

TFA/Technical: Thorough medical history, triage sensitivity (dyspnea, hind limb paresis), performance of rapid tests (NT-proBNP), blood pressure, ECG; explanation of the benefits of diagnostics; medication refills, reminder calls.

Veterinarian: Identify risk factors (breed, noise, rhythm findings), define screening protocols, referral to cardiology if necessary; indication for clopidogrel/beta-blockers/felycin-CA1; emergency care for CHF/ATE; structured follow-up examinations and owner information.

---

Frequently asked questions (FAQ)

1) How can I, as the owner, tell if my cat has [something]? Hypertrophic cardiomyopathy cat could suffer?

At home, early signs are often subtle or completely absent. That's precisely what makes it so difficult. Hypertrophic cardiomyopathy cat So insidious. A heart murmur detected by your veterinarian can be a clue, but it's not proof. Common early observations include reduced playfulness, getting out of breath more easily, or longer recovery times after excitement. Very important is the Resting respiratory rateCount how many times your cat's chest rises and falls per minute while sleeping. Values below 30/min They are generally considered to be calming.

A sustained increase above 30–35/min or significant respiratory effort (mouth breathing, flank breathing) is a Warning signs and should immediately This needs to be investigated. Later, serious signs include shortness of breath due to pulmonary edema/pleural effusion or sudden, painful hind limb paralysis due to thromboembolism. Sudden collapse can also occur. Keep in mind: Coughing is atypical for heart problems in cats. A definitive diagnosis can only be made via echocardiography; as a pragmatic preliminary step, NT-proBNP tests can provide indications in practice. International information websites like Cornell explain the symptoms in layman-friendly terms, but this does not replace a veterinary examination.

2) Which tests are really necessary to Hypertrophic cardiomyopathy cat to diagnose?

The basis is the clinical examination with auscultation. If noises or arrhythmias are detected, this does not rule anything out or exclude anything – some cats with pronounced [unclear] Hypertrophic cardiomyopathy cat have no Noise. In general practice, I use NT-proBNP: In cases of unexplained dyspnea, the test helps to differentiate heart failure from non-cardiac causes; as a screening tool in seemingly healthy cats, it's one piece of the puzzle, but by no means perfect. X-rays show signs of congestion/effusion, but are not suitable for reliably detecting mild HCM.

Gold standard Echocardiography is performed by a specialized cardiologist or in-house with the necessary expertise. There, we measure wall thickness, assess papillary muscles, atrial size, SAM (simultaneous atrial tachycardia), and flow patterns, and classify according to the ACVIM (Accelerated Cardiovascular Imaging) scheme. Depending on the results, we schedule follow-up checks – approximately every six months to annually for low-risk patients, and more frequently for patients with risk factors. This approach is based on international guidelines (ACVIM) and current reviews.

3) How will Hypertrophic cardiomyopathy cat Should my cat be treated as long as she isn't showing any symptoms?

In the subclinical stage, we aim to, To reduce risks and slow progression. If the left atrium has exceeded a certain size or if other risk factors are present, I usually recommend... Clopidogrel for thromboembolism prophylaxis. If relevant ventricular arrhythmias are present, selective intervention occurs Beta blockers (e.g., atenolol) are being considered. A completely new possibility is the hypertrophy to approach it therapeutically oneself:

In the USA, since 2025 Felycin®-CA1 (Sirolimus, delayed-release) Conditionally permitted for the treatment of subclinical ventricular hypertrophy Hypertrophic cardiomyopathy cat. Once weekly orally, well tolerated in the registration study, but clear Contraindications (Diabetes, liver disease, ATE, CHF) and Interactions Note the presence of CYP3A4/P-gp inhibitors. Important: This medication is not currently available in all countries, and the decision should be made by experienced professionals with structured follow-up care.

4) What is the prognosis for Hypertrophic cardiomyopathy cat – and what can I contribute myself?

The forecast is variable. Many cats remain stable for years; others experience early complications such as CHF or thromboembolism. Factors influencing this include the degree of wall thickening, the size of the left atrium, the presence of SAM/obstruction, arrhythmias, and biomarkers. What you can do: Respiratory rate during sleep Count and document regularly; report any increase promptly. Administer medication reliably, attend follow-up appointments, avoid stress, and normalize body weight (excess weight increases respiratory effort).

If there are signs of thromboembolism (painful hind leg paralysis, cold/pale paws) immediately Presenting the patient clinically – every minute counts. A structured emergency plan, which we discuss during the recheck, provides peace of mind. International reviews describe how structured follow-up and early intervention can improve outcomes; new disease-modifying approaches such as felycin-CA1 could further improve the long-term prognosis for selected patients, but require consistent monitoring.

5) Should every at-risk cat be on Hypertrophic cardiomyopathy cat to be screened – and from what age?

For clearly predisposed breeds, I recommend..., from young adulthood (e.g., 1–2 years) to discuss structured screening. A clinical examination is advisable, and—depending on the individual situation—NT-proBNP can be used as a pragmatic tool. Echocardiography is the treatment of choice, especially if there is a murmur, an arrhythmia, elevated NT-proBNP levels, or a family history.

For a normal initial ultrasound, I plan to use ultrasound on breeding animals or highly predisposed cats. repeated checks (e.g. every 1-2 years), since Hypertrophic cardiomyopathy cat It can also manifest later. For patients without immediate access to cardiology, biomarker-based triage can initially be helpful, but it does not replace ultrasound. Articles in JAVMA discuss the pros and cons of screening and provide a differentiated classification of NT-proBNP; the ACVIM guideline provides the conceptual framework for the stages and risk groups.

---

Detailed summary and classification

Hypertrophic cardiomyopathy cat It is the most common primary heart disease in cats and affects a significant proportion of the population. Characteristic features include: concentric thickening the left ventricle and resulting diastolic dysfunction. Because Hypertrophic cardiomyopathy cat often long subclinical If it remains, it is easily overlooked in general practice. This is precisely where the value of a structured, practical approach lies: systematic auscultation, risk-based Screening, pragmatic Biomarkers (NT-proBNP) and – as the gold standard – the Echocardiography. The consultation should make it clear that Hypertrophic cardiomyopathy cat although it often goes undetected, but with early diagnosis the chance increases to develop complications such as Heart failure or Thromboembolism to delay.

In my own daily clinical practice, I begin when there is a suspicion of Hypertrophic cardiomyopathy cat With clear communication: What does the finding mean? What are the next sensible steps? How do we interpret NT-proBNP and X-ray results? Why is ultrasound crucial? I show patients how to reliably measure their respiratory rate at home. This simple parameter is an early warning system – it often allows for the detection of developing fluid accumulation in the lungs before severe shortness of breath develops. I also discuss an emergency plan: What to do in case of sudden respiratory distress. DyspneaWhat do cold, painful hind paws mean? Which medications need to be given immediately, or what other measures should be taken? not Take matters into your own hands?

Therapeutically, I consistently distinguish between the subclinical stage and clinical disease. In the case of subclinical Hypertrophic cardiomyopathy cat I usually recommend those with a large atrium Clopidogrel for thromboembolism prophylaxis, because arterial thrombi These are among the most feared complications. If relevant ventricular arrhythmias are present, we consider... Beta blockers like atenolol – always individually and according to the echocardiogram findings. Fluid therapies I use this method for hospitalized cats Hypertrophic cardiomyopathy cat proceed very cautiously to avoid triggering decompensation.

A milestone is the possibility of disease-modifying therapy in the subclinical stage: Felycin®-CA1 (Sirolimus, delayed-release) is conditionally approved in the USA for the treatment of ventricular hypertrophy with Hypertrophic cardiomyopathy cat. Designed as a weekly dose, it was able to significantly reduce wall thickness in a study. In practice, this means that in suitable patients, in addition to pure risk control, it is now possible to use it direct to address pathological remodeling. Nevertheless, diligence remains mandatory: Hypertrophic cardiomyopathy cat It cannot be addressed using a single metric. Clear [measures] are needed. Inclusion criteria, exclusion of Contraindications (including diabetes, liver disease, ATE, CHF), examination of possible Interactions (CYP3A4/P-gp), closely woven checks and an honest cost-benefit analysis with the owners. In Europe, the supply situation and legal classification must be examined separately; here I provide transparent and evidence-based advice.

For the Long-term care of cats with Hypertrophic cardiomyopathy cat has a Team approach Proven effective. The registration desk prioritizes high-risk patients, provides information about re-checks, and ensures reliable appointment scheduling. Veterinary assistants are key personnel for Medical history, triage, Biomarker tests, Blood pressure measurement and Owner information. The veterinary management defines Protocols, sets indications, performs the echocardiography (or refers to cardiology) and designs the Emergency care. In every phase empathy essential: Hypertrophic cardiomyopathy cat Uncertain – clear, respectful communication makes all the difference.

The forecast is individually. In mild cases of Hypertrophic cardiomyopathy cat Cats with small atria and no obstruction can live many years without problems. However, with significantly enlarged atria, pronounced hypertrophy, obstruction, and arrhythmias, the risk of decompensation and thromboembolism increases. Therefore, structured rechecks – including clinical examination, possibly NT-proBNP, blood pressure and echocardiography – the core of any serious care. Additionally, the following is recommended in the case of Hypertrophic cardiomyopathy cat close collaboration with specialized cardiologists, especially when it comes to complex decisions (e.g. anticoagulation vs. bleeding risk, antiarrhythmics, initiation of felycin-CA1).

In summary: Hypertrophic cardiomyopathy cat It is common, insidious, and multifaceted. It requires a early diagnosis, risk-based therapy and consistent follow-up care. Thanks to new therapeutic approaches, additional options are available which we can use – carefully selected and closely monitored – for the benefit of our patients. With a structured, empathetic team approach, clear plans for daily life at home, and reliable monitoring, the Hypertrophic cardiomyopathy cat today, we manage cats in such a way that the quality of life and lifespan of many cats noticeably benefit.

(Further international resources: ACVIM Consensus, Cornell Feline Health Center, JAVMA article and FDA fact sheet; links above.)

Important NOTE

This article is for informational purposes only and does not replace none Veterinary examination. If your cat experiences difficulty breathing, sudden paralysis, or a significant deterioration in its condition, take it to the vet. immediately in the doctor's office or emergency room.